Google News – EMA (biotech/pharma) External News
Life Sciences & Pharma Articles
Google News – EMA (biotech/pharma) External News
InBrain Pharma's intracerebroventricular dopamine bags positive EMA opinion - Manufacturing Chemist
Google News – EMA (biotech/pharma) External News
EU plan to make medical leaflets digital opens pharma lobbying debate - Euractiv
Google News – FDA (biotech/pharma) External News
FDA hits Newron’s phase 3 schizophrenia trial with clinical hold in US after patient death - Fierce Biotech
Google News – FDA (biotech/pharma) External News
OKYO Pharma reports FDA feedback, advances urcosimod into Phase 3 trial for neuropathic corneal pain - Proactive financial news
Google News – FDA (biotech/pharma) External News
The week in pharma: action, reaction and insight – week to July 10, 2026 - The Pharma Letter
Google News – FDA (biotech/pharma) External News
FDA discloses why drugs don’t make it to market. A pharma company says it’s bad for business - Yahoo Finance
Google News – FDA (biotech/pharma) External News
Ascelia Pharma Defends Orviglance Trial After FDA Rejection, Shares Plunge 79% in 2026 - finance.biggo.com
Google News – FDA (biotech/pharma) External News
WuXi Biologics earns FDA approval for China drug substance facility - megaproject.com
Google News – FDA (biotech/pharma) External News
Maharashtra FDA seizes Cadila Pharma's Rs 2.45 cr worth Aciloc stock; orders market recall over "deceptive" branding - ANI News
Google News – Clinical Trials External News
Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress - The Manila Times
Google News – Clinical Trials External News
Intellia Therapeutics Provides Update on MAGNITUDE Clinical Trials of Nexiguran Ziclumeran (nex-z) - Intellia Therapeutics
Google News – Pharmaceuticals External News
FDA clears Quoin Pharmaceuticals’ QRX003 IND for Phase II PSS trial - Yahoo
Google News – Pharmaceuticals External News
Sumitomo Mitsui Trust Group Inc. Has $65.48 Million Holdings in Teva Pharmaceutical Industries Ltd. $TEVA - MarketBeat
Google News – Pharmaceuticals External News